# Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate

> **NCT00931398** · PHASE4 · WITHDRAWN · sponsor: **University of Pittsburgh**

## Conditions studied

- Attention-Deficit/Hyperactivity Disorder (ADHD)

## Interventions

- **DRUG:** methylphenidate HCl (Concerta)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00931398
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-04
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was not initiated due to lack of funding by the sponsor
- **Last updated:** 2012-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931398, "Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00931398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*